安全性薬理学の継承と革新を通じ
優れた医薬品の開発に貢献します
Succession and Innovation of Safety Pharmacology for Contribution to the Development of Superior Pharmaceuticals
  2. HOME

2024年度の国際安全性薬理学会（SPS）は、米国サンディエゴで開催されます。

We are soliciting questions from our members for the 15th Annual Meeting Safety Pharmacology Q&A Session.
Deadline: Friday, December 15, 2023
For details, please click on the following page and follow the instructions provided: About Q&A session
Please note that the question solicitation is targeted specifically at JSPS members, so please access it after logging in.

Downtown Osaka


Highlights of the 15th Annual Meeting of JSPS (updated as of Nov. 10, 2023)

【第5回scChemRISC研究会開催のお知らせ】
来る12月8日に第5回scChemRISC研究会「ES・iPS細胞の可能性を探る」をテーマに開催します。
この研究会は、幹細胞を用いた化学物質に関するリスク情報の共有を促進することを目的としており、
学術研究者のみならず、新たな安全性および毒性予測技術を開発する企業の研究者や関係者の方々との
活発な意見交換を期待しております。皆様のご参加をお待ちしております。

以下、第6回医薬品毒性機序研究会からの開催案内が届きましたのでご案内いたします。

In March, we released the ICH E14/S7B Q&A, followed by the Training Materials (TM) in April. Below, we have arranged opportunities for you to acquire information. We believe that utilizing these resources will enhance your understanding.

ICH E14/S7B Q&A Training Materials have been released.

  • E14/S7B Initial Training Material
  • E14/S7B Initial Training Material – Example Supplemental File 

You can access the relevant files using the following steps:

Access through the ICH Safety guideline link.

  • Click the 'V' mark on the right side of S7A-S7B Pharmacology studies.
  • Click the '＞' mark on the left side of E14/S7B IWG.

ICH E14/S7B Q&A have been released.

You can access the relevant files using the following steps:

Access through the ICH Safety guideline link.

  • Click the 'V' mark on the right side of S7A-S7B Pharmacology studies.
  • Click the '＞' mark on the left side of E14/S7B IWG.

Furthermore, regarding the training materials that are scheduled to be released concurrently, they will be made available in the near future. We will notify you again when they are released.

メインメニュー